Natco Pharma launches generic version of pomalidomide

10 May 2017 Evaluate

Natco Pharma has launched a generic version of pomalidomide 1 mg, 2 mg, and 4 mg capsules in India. Pomalidomide is sold by Celgene Inc., in the USA, under the brand name ‘Pomalyst’.

Pomalidomide is a thalidomide analogue indicated, in combination with dexamethasone, for patients with multiple myeloma (a type of blood cancer) who have received at least two prior therapies including lenalidomide and a proteasome inhibitor and have demonstrated disease progression on or within 60 days of completion of the last therapy.

Natco will market generic pomalidomide capsules under its brand name POMALID in India. Natco priced its generic medicine of POMALID 1 mg, 2 mg, and 4 mg capsules at an MRP of Rs 5000, Rs 10,000 and Rs 20,000 respectively for a monthly pack of 21 capsules.

Natco Pharma Share Price

817.65 4.00 (0.49%)
28-Jan-2026 12:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1618.95
Dr. Reddys Lab 1220.75
Cipla 1315.20
Zydus Lifesciences 892.30
Lupin 2123.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×